Monitoring T cell alloreactivity after organ transplantation

Clinical and Experimental Immunology

Volumn 142, Issue 2, 2005, Pages 229-232

  Bradley, J Andrew ^a,b   Bolton, E M ^a   Pettigrew, G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; HLA ANTIGEN;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; CELL PROLIFERATION; EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; HLA SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

GRAFT REJECTION; HUMANS; ISOANTIGENS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 27644557268     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02943.x     Document Type: Editorial

References (21)

1. Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005; 5:843-9.
2. Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB. Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant 2005; 5:874-86.
3. Joosten SA, Sijpkens YW, van Kooten C, Paul LC. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005; 68:1-13.
4. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 2004; 23:S187-93.
5. Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003; 3:525-33.
6. Rogers NJ, Lechler RI. Allorecognition. Am J Transplant 2001; 1:97-102.
7. Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev 2003; 196:247-64.
8. Van Besouw NM, Zuifderwijk JM, Vaessen LMB et al. The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation. Clin Exp Immunol 2005; 141:534-40.
9. Hricik DE, Rodriguez V, Riley J et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003; 3:878-84.
10. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class II-defi-cient mice. Proc Natl Acad Sci U S A 1993; 90:3373-7.
11. Csencsits K, Wood SC, Lu G et al. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response. Eur J Immunol 2005; 35:843-51.
12. Liu Z, Harris PE, Colovai AI, Reed EF, Maffei A, Suciu-Foca N. Indirect recognition of donor MHC Class II antigens in human transplantation. Clin Immunol Immunopathol 1996; 78:228-35.
13. Hornick PI, Mason PD, Yacoub MH, Rose ML, Batchelor R, Lechler RI. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation 1998; 97:1257-63.
14. Mason PD, Robinson CM, Lechler RI. Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int 1996; 50:1019-25.
15. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler R. Comparison of the direct and indirect pathways of allorecognition in chronic allograft failure. Transplant Proc 2001; 33:449.
16. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167:7199-206.
17. Poggio ED, Clemente M, Riley J et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol 2004; 15:1952-60.
18. Ciubotariu R, Liu Z, Colovai AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101:398-405.
19. Hornick PI, Mason PD, Baker RJ et al. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 2000; 101:2405-10.
20. SivaSai KS, Smith MA, Poindexter NJ et al. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 1999; 67:1094-8.
21. Reznik SI, Jaramillo A, SivaSai KS et al Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001; 1:228-35.